11/19
07:30 am
bntx
BioNTech SE (NASDAQ: BNTX) is now covered by analysts at Berenberg Bank. They set a "buy" rating and a $130.00 price target on the stock.
Low
Report
BioNTech SE (NASDAQ: BNTX) is now covered by analysts at Berenberg Bank. They set a "buy" rating and a $130.00 price target on the stock.
11/19
07:30 am
bntx
BioNTech SE (NASDAQ: BNTX) was upgraded by analysts at Evercore ISI from an "in-line" rating to an "outperform" rating. They now have a $125.00 price target on the stock, up previously from $110.00.
Low
Report
BioNTech SE (NASDAQ: BNTX) was upgraded by analysts at Evercore ISI from an "in-line" rating to an "outperform" rating. They now have a $125.00 price target on the stock, up previously from $110.00.
11/18
08:09 am
bntx
BioNTech SE (NASDAQ: BNTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $150.00 price target on the stock.
Low
Report
BioNTech SE (NASDAQ: BNTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $150.00 price target on the stock.
11/14
11:23 am
bntx
BioNTech SE (NASDAQ: BNTX) had its "buy" rating re-affirmed by analysts at Canaccord Genuity Group Inc.. They now have a $171.00 price target on the stock.
Medium
Report
BioNTech SE (NASDAQ: BNTX) had its "buy" rating re-affirmed by analysts at Canaccord Genuity Group Inc.. They now have a $171.00 price target on the stock.
11/13
06:45 am
bntx
BioNTech to Acquire Biotheus to Boost Oncology Strategy
Medium
Report
BioNTech to Acquire Biotheus to Boost Oncology Strategy
11/5
02:32 pm
bntx
BioNTech SE (NASDAQ: BNTX) had its price target lowered by analysts at TD Cowen from $132.00 to $122.00. They now have a "hold" rating on the stock.
Low
Report
BioNTech SE (NASDAQ: BNTX) had its price target lowered by analysts at TD Cowen from $132.00 to $122.00. They now have a "hold" rating on the stock.
11/5
02:14 am
bntx
BioNTech SE (BNTX) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic Advancements ... [Yahoo! Finance]
Low
Report
BioNTech SE (BNTX) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic Advancements ... [Yahoo! Finance]
11/4
10:31 am
bntx
BioNTech SE (NASDAQ: BNTX) had its price target lowered by analysts at JPMorgan Chase & Co. from $125.00 to $124.00. They now have a "neutral" rating on the stock.
Low
Report
BioNTech SE (NASDAQ: BNTX) had its price target lowered by analysts at JPMorgan Chase & Co. from $125.00 to $124.00. They now have a "neutral" rating on the stock.
11/4
06:45 am
bntx
BioNTech Announces Third Quarter 2024 Financial Results and Corporate Update
Medium
Report
BioNTech Announces Third Quarter 2024 Financial Results and Corporate Update
10/31
07:45 am
bntx
BioNTech to Host Innovation Series R&D Day on November 14, 2024
Low
Report
BioNTech to Host Innovation Series R&D Day on November 14, 2024
10/21
11:07 am
bntx
BioNTech SE (NASDAQ: BNTX) had its price target raised by analysts at TD Cowen from $85.00 to $132.00. They now have a "hold" rating on the stock.
Low
Report
BioNTech SE (NASDAQ: BNTX) had its price target raised by analysts at TD Cowen from $85.00 to $132.00. They now have a "hold" rating on the stock.
10/21
06:45 am
bntx
BioNTech to Report Third Quarter 2024 Financial Results and Corporate Update on November 4, 2024
Low
Report
BioNTech to Report Third Quarter 2024 Financial Results and Corporate Update on November 4, 2024
10/7
02:12 pm
bntx
BioNTech SE (NASDAQ: BNTX) had its price target raised by analysts at HSBC Holdings plc from $97.00 to $136.00. They now have a "buy" rating on the stock.
Low
Report
BioNTech SE (NASDAQ: BNTX) had its price target raised by analysts at HSBC Holdings plc from $97.00 to $136.00. They now have a "buy" rating on the stock.
10/7
08:17 am
bntx
BioNTech SE (NASDAQ: BNTX) had its price target raised by analysts at HC Wainwright from $113.00 to $150.00. They now have a "buy" rating on the stock.
Low
Report
BioNTech SE (NASDAQ: BNTX) had its price target raised by analysts at HC Wainwright from $113.00 to $150.00. They now have a "buy" rating on the stock.
10/1
06:00 am
bntx
BioNTech Highlights AI Capabilities and R&D Use Cases at Inaugural AI Day
Low
Report
BioNTech Highlights AI Capabilities and R&D Use Cases at Inaugural AI Day
9/24
11:58 am
bntx
Pfizer Canada and BioNTech Receive Health Canada Approval of Omicron KP.2 Variant Adapted COVID-19 Vaccine [Yahoo! Finance]
Low
Report
Pfizer Canada and BioNTech Receive Health Canada Approval of Omicron KP.2 Variant Adapted COVID-19 Vaccine [Yahoo! Finance]
9/24
08:06 am
bntx
BioNTech SE (NASDAQ: BNTX) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $145.00 price target on the stock, up previously from $93.00.
Low
Report
BioNTech SE (NASDAQ: BNTX) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $145.00 price target on the stock, up previously from $93.00.
9/20
08:27 am
bntx
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union [Yahoo! Finance]
Low
Report
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union [Yahoo! Finance]
9/20
08:10 am
bntx
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union
Low
Report
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union
9/19
02:03 pm
bntx
BioNTech SE (NASDAQ: BNTX) had its price target raised by analysts at Deutsche Bank Aktiengesellschaft from $95.00 to $150.00. They now have a "buy" rating on the stock.
Low
Report
BioNTech SE (NASDAQ: BNTX) had its price target raised by analysts at Deutsche Bank Aktiengesellschaft from $95.00 to $150.00. They now have a "buy" rating on the stock.
9/18
09:15 am
bntx
BioNTech SE (NASDAQ: BNTX) had its price target raised by analysts at UBS Group AG from $97.00 to $131.00. They now have a "neutral" rating on the stock.
Medium
Report
BioNTech SE (NASDAQ: BNTX) had its price target raised by analysts at UBS Group AG from $97.00 to $131.00. They now have a "neutral" rating on the stock.
9/17
07:33 am
bntx
BioNTech SE (NASDAQ: BNTX) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $150.00 price target on the stock, up previously from $96.00.
Low
Report
BioNTech SE (NASDAQ: BNTX) was upgraded by analysts at Jefferies Financial Group Inc. from a "hold" rating to a "buy" rating. They now have a $150.00 price target on the stock, up previously from $96.00.
9/17
06:45 am
bntx
BioNTech to Host AI Day as an Edition of its Innovation Series on October 1, 2024
Low
Report
BioNTech to Host AI Day as an Edition of its Innovation Series on October 1, 2024
9/16
09:13 am
bntx
BioNTech SE (NASDAQ: BNTX) had its price target raised by analysts at Bank of America Co. from $125.00 to $150.00. They now have a "buy" rating on the stock.
Low
Report
BioNTech SE (NASDAQ: BNTX) had its price target raised by analysts at Bank of America Co. from $125.00 to $150.00. They now have a "buy" rating on the stock.
9/16
08:03 am
bntx
BioNTech SE (NASDAQ: BNTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $113.00 price target on the stock.
Low
Report
BioNTech SE (NASDAQ: BNTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $113.00 price target on the stock.